Verbatim Enters 3D Printer Filament Market
It’s often a sign that a market is expanding rapidly when you begin finding large companies, known for products outside a space, bringing to market brand new products within that space. We saw it happen when Apple
entered the smartphone market, when Microsoft entered the video game console market, and when more recently, Autodesk announced that they will be producing a new SLA based 3D printer, called Spark, along with a 3D printing platform known by the same name.
As we probably mention almost on a daily basis, the materials market within the 3D printing industry is beginning to expand in a dramatic way, with billions of dollars to be made over the next several years. One company, traditionally known for their data storage devices such as hard drives, Blu-rays, USB drives, and other forms of computer memory, Verbatim, has announced this week that they will enter the 3D printer filament market.
The company which was founded 45 years ago, and was influential in the development of optical media recording and the CD/DVD family of products, will begin offering a variety of filament products beginning next month in Europe.
“The 3D printing industry is currently undergoing a massive transformation and enjoying unprecedented growth that is estimated to reach a value of $669 million (EUR500 million) in 2014, according to Gartner,” stated the company. “Now, new and more technologically advanced 3D printers are increasingly being introduced that target use in homes, schools and universities, and key business and industrial applications.”
The Verbatim branded filament will include both ABS and PLA thermoplastics, both of which will come in 1.75mm and 3mm sizes. Multiple colors will be available, and the filament will come in 1kg spools. According to the company, the filament is produced with the highest quality materials, and will be distributed in bags which have been vacuum sealed.
It is interesting to note, that Verbatim’s parent company, Mitsubishi Chemical, announced last month that they are working on specialized 3D printer filaments which combine the best attributes of both PLA and ABS plastics. The filament, which they call Durabio is a bio-based plastic resin which can be used within 3D printers as well as other manufacturing applications.
Although Verbatin hasn’t commented on who their Japanese manufacturing partner is for this project, it could be guessed with relatively high confidence, that Mitsubishi Chemical are the ones manufacturing these new filaments.
Let’s hear your thoughts on the news of Verbatim entering the material side of the 3D printing market, in the Verbatim filament forum thread on 3DPB.com.
Subscribe to Our Email Newsletter
Stay up-to-date on all the latest news from the 3D printing industry and receive information and offers from third party vendors.
Print Services
Upload your 3D Models and get them printed quickly and efficiently.
You May Also Like
Printing Money Episode 38: Additive Manufacturing Deal Analysis with Rajeev Kulkarni
Welcome to Printing Money Episode 38. Rajeev Kulkarni returns for this episode, and we find it hard to believe it’s been nearly two years since his first appearance. In the interim,...
3D Printing News Briefs, May 14, 2026: Project Calls, Reseller, Reconstructive Surgery, & More
We’re starting off today’s 3D Printing News Briefs with two new Project Calls from America Makes. We’ll move on to some more business, with Axtra3D expanding its presence in North...
Fabric8Labs & University of Illinois Collaborate on 3D Printed Copper Cold Plates for Data Centers
Collaboration between emerging technology enterprises and research universities is one of the most consistently winning tactics for any nation building (or rebuilding) an industrial ecosystem. It’s an especially constructive approach...
3D Printing News Briefs: May 7, 2026: Metal Powder Bed Fusion, Surgical Plates, & More
In today’s 3D Printing News Briefs, we’ll start with a strategic collaboration to advance next-generation metal additive manufacturing (AM), before moving on to funding for surgical research. We’ll end with...






































